These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1979000)

  • 21. [Pharmacologic therapy for patients with stable chronic obstructive pulmonary disease--emphasis on inhaled agents].
    Nishimura K; Ikeda A; Koyama H; Tsukino M; Hajiro T; Izumi T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():75-8. PubMed ID: 9216189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of inhaled corticosteroids on exhaled nitric oxide in stable chronic obstructive pulmonary disease.
    Zietkowski Z; Kucharewicz I; Bodzenta-Lukaszyk A
    Respir Med; 2005 Jul; 99(7):816-24. PubMed ID: 15939243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic respiratory insufficiency in general practice].
    Anderhub HP; Keller R
    Schweiz Med Wochenschr; 1979 Oct; 109(40):1493-7. PubMed ID: 42973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of the effect of chronic steroid inhalation therapy on the state of the upper airway in patients with chronic obstructive pulmonary disease].
    Kozak E; Maniecka-Aleksandrowicz B; Frank-Piskorska A; Witman D
    Pneumonol Alergol Pol; 1991; 59(9-10):33-7. PubMed ID: 1843644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of magnesium serum levels in patients with acute ischemic stroke and acute infections.
    Cojocaru IM; Cojocaru M; Tănăsescu R; Iacob SA; Iliescu I
    Rom J Intern Med; 2009; 47(2):169-71. PubMed ID: 20067167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum magnesium and digitalis toxicity in chronic obstructive lung disease.
    Jethliya RS; Bhatnagar HN; Shah DR
    J Indian Med Assoc; 1979 Jun; 72(12):269-72. PubMed ID: 521652
    [No Abstract]   [Full Text] [Related]  

  • 27. [Long term experiences following switching from oral administration to corticosteroid inhalation in patients with chronic aspecific lung diseases].
    Berg WC; Steenhuis EJ; Wesseling H; de Vries K
    Ned Tijdschr Geneeskd; 1979 May; 123(19):771-8. PubMed ID: 440462
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hypomagnesemia: a rare adverse effect of diuretic therapy?].
    Laake K; Aspøy B; Foss OP; Horvei C
    Tidsskr Nor Laegeforen; 1978 May; 98(15):799. PubMed ID: 675623
    [No Abstract]   [Full Text] [Related]  

  • 29. Steroids in COPD: the nearly eternal question.
    Anthonisen NR
    Chest; 1999 Jan; 115(1):3-4. PubMed ID: 9925052
    [No Abstract]   [Full Text] [Related]  

  • 30. A drug use review study in patients with obstructive lung disease. Assessment of the quality of drug therapy.
    Van den Brink G; Bollen CW; Van de Wall OE; Hoeve LJ; Porsius AJ
    Pharm Weekbl Sci; 1992 Oct; 14(5):311-5. PubMed ID: 1359504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Phlebothromboses as complications of long-term corticoid therapy in chronic-obstructive lung diseases].
    Kirsten D; Sedlarik K; Meister W
    Z Arztl Fortbild (Jena); 1979 May; 73(9):428-30. PubMed ID: 483885
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease.
    Barnes PJ
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 1):342-4; discussioin 344. PubMed ID: 10673166
    [No Abstract]   [Full Text] [Related]  

  • 33. [Drug therapy of obstructive lung diseases].
    Astner ST; Huber RM
    Internist (Berl); 2001 Jul; 42(7):1040-9. PubMed ID: 11476048
    [No Abstract]   [Full Text] [Related]  

  • 34. Corticosteroids in obstructive lung disease.
    Orie NG; Wiers PW; Weller AA; Sluiter HJ; de Vries K
    Acta Tuberc Pneumol Belg; 1977; 68(1):31-7. PubMed ID: 930792
    [No Abstract]   [Full Text] [Related]  

  • 35. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease.
    Rogol PR
    N Engl J Med; 1993 Apr; 328(14):1044. PubMed ID: 8450867
    [No Abstract]   [Full Text] [Related]  

  • 36. [Is there a renaissance of oral theophylline therapy in chronic obstructive airway syndrome?].
    Fenner HG
    ZFA (Stuttgart); 1981 Jul; 57(21):1480-4. PubMed ID: 7281936
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled corticosteroids and chronic obstructive pulmonary disease.
    Sapey E; Langford NJ; Kendall MJ
    J Clin Pharm Ther; 2000 Aug; 25(4):235-8. PubMed ID: 10971772
    [No Abstract]   [Full Text] [Related]  

  • 38. Patterns of drug taking in patients with chronic airflow obstruction.
    James PN; Anderson JB; Prior JG; White JP; Henry JA; Cochrane GM
    Postgrad Med J; 1985 Jan; 61(711):7-10. PubMed ID: 2859583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroidphobia and the pulmonary patient.
    Della Bella LA
    Am J Nurs; 1992 Feb; 92(2):26-9. PubMed ID: 1739111
    [No Abstract]   [Full Text] [Related]  

  • 40. Are corticosteroids worth the risks in obstructive lung diseases in adults?
    Morse JO
    Ariz Med; 1976 Sep; 33(9):720-31. PubMed ID: 971126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.